2022
DOI: 10.1016/j.radcr.2022.02.022
|View full text |Cite
|
Sign up to set email alerts
|

F-FDG18PET/CT incidental detection of tumor-to-tumor metastasis in patients investigated for squamous cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…A total of 37 studies dealing with other topics, such as neuroimaging, pathology or other anatomic localizations, were excluded; the last screening examined the full texts. Finally, we included eight articles in our review ( Table 2 ) [ 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 ].…”
Section: Review Of Available Evidence On Metastatic Lung Cancer Withi...mentioning
confidence: 99%
See 2 more Smart Citations
“…A total of 37 studies dealing with other topics, such as neuroimaging, pathology or other anatomic localizations, were excluded; the last screening examined the full texts. Finally, we included eight articles in our review ( Table 2 ) [ 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 ].…”
Section: Review Of Available Evidence On Metastatic Lung Cancer Withi...mentioning
confidence: 99%
“…Rais G. et al reported that FDG-PET/CT can provide reliable diagnostic information about TTM and serve to guide a biopsy procedure for a specific metastatic lesion, even if most cases were discovered incidentally in living patients or during autopsy. Furthermore, the authors reported the first case of an incidental PET/CT finding consistent with a TTM from lung cancer to RCC [ 93 ].…”
Section: Review Of Available Evidence On Metastatic Lung Cancer Withi...mentioning
confidence: 99%
See 1 more Smart Citation
“…To date, more than 100 TTM cases were published in the literature and lung cancers are the most common donors in TTM, followed by carcinomas of the breast, gastrointestinal tract, prostate, and thyroid. The most frequent recipient tumor is renal cell carcinoma, followed by meningioma and thyroid tumor [2][3][4][5]. Thymoma is considered a rare neoplasm with an overall incidence of 1.5 cases per million whereas the incidence of thymic malignancies is 0.13 cases/100.000 persons/year [6].…”
Section: Introductionmentioning
confidence: 99%